MAPT and Alzheimer disease: The GSK-3β inhibitor, lithium chloride can reverse cognitive deficits and tau hyperphosphorylation in an in vivo AD model, which was established by injecting Aβ42 into the hindbrain ventricle of zebrafish embryos (Nery et al., 2014).